BRYNJELSEN SEAN (President & CEO) sold 12.6% of their position (120K shares) of ETON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $3.83M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/29/2026ACC: 0001437749-26-018879
DirectorOfficer· President & CEO
Since Nov 2018
-120K
Net shares
Net seller
$3.83M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
120K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−119.85K
Price / share
$31.88
Trade value
$3.82M
% of position
12.6%
5/28/2026
953.69K→833.84K
Common Stock
Direct
Shares
−148.00
Price / share
$32.67
Trade value
$4.84K
% of position
0.0%
5/28/2026
833.84K→833.69K
Total
Net shares
−120K
Net value
-$3.83M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/28/2026 | S · Sale | −119.85K | $31.88 | $3.82M | 12.6% | 953.69K | 833.84K |
| Common Stock Direct | 5/28/2026 | S · Sale | −148.00 | $32.67 | $4.84K | 0.0% | 833.84K | 833.69K |
| Total | −120K | -$3.83M | ||||||
Derivative Transactions0
No derivative transactions reported